Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

Abstract Objective Convalescent plasma has been tried as therapy for various viral infections. Early observational studies of convalescent plasma treatment for hospitalized COVID-19 patients were promising, but randomized controlled studies were lacking at the time. The objective of this study was t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Karin Holm, Maria N. Lundgren, Jens Kjeldsen-Kragh, Oskar Ljungquist, Blenda Böttiger, Christian Wikén, Jonas Öberg, Nils Fernström, Ebba Rosendal, Anna K. Överby, Julia Wigren Byström, Mattias Forsell, Mona Landin-Olsson, Magnus Rasmussen
Format: article
Langue:EN
Publié: BMC 2021
Sujets:
SARS-CoV2
COVID-19
Convalescent plasma
Oxygen therapy
Desaturation
Medicine
R
Biology (General)
QH301-705.5
Science (General)
Q1-390
Accès en ligne:https://doaj.org/article/b7713b8a6ec64937b394d31d9f097f2f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/b7713b8a6ec64937b394d31d9f097f2f

Documents similaires